Clinical trial
Follow Fever to Decide: Determination of an Algorithm to Quantify and Qualify the Circadian Rhythmicity
NCT04311268 is registered in ClinicalTrials.gov with Slb Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Follow Fever to Decide: Determination of an Algorithm to Quantify and Qualify the Circadian Rhythmicity
- Lead sponsor
- Slb Pharma
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 13, 2020
- Completion date
- December 18, 2021
- Enrollment
- 306 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.